- U.S. Cerebral palsy, a non-progressive neurological disorder affecting movement and posture, is becoming a central focus in pediatric and rehabilitative care across the U.S., supported by early diagnosis initiatives, increasing therapy adoption, and advancements in assistive technologies
- The rising demand for cerebral palsy treatment is primarily fueled by improved neonatal care, higher survival rates of preterm infants, and expanded access to comprehensive therapies including physical, occupational, and speech therapy
- Therapy segment is prevalent due to its foundational role in long-term management, functional improvement, and quality of life enhancement for individuals with the condition
- Children constituted the largest population segment in 2024, reflecting the early onset of the disorder and the emphasis on early intervention programs in pediatric healthcare settings
- Spastic cerebral palsy emerged as the dominant type in the U.S. market with a share of 73.3% in 2024, due to its high prevalence and the need for consistent multidisciplinary care tailored to manage muscle stiffness and mobility challenges
